Antique Initiates Coverage on Leading Indian Hospital Stocks: Growth and Investment Insights

India’s organized hospital sector is poised for significant growth, driven by robust healthcare demand, expanding capacities, and rising insurance penetration. Antique, a respected brokerage house, has initiated coverage on four major hospital chains—Apollo Hospitals, Medanta (Global Health), Healthcare Global Enterprises (HCG), and Max Healthcare Institute. Alongside Artemis Medicare Services, they are positioned to benefit from a multi-year expansion phase in India’s healthcare delivery market.

Sector Overview: Growth Drivers and Market Outlook

The healthcare delivery sector in India is expected to grow at a compound annual growth rate (CAGR) of 10-12% to reach approximately Rs 12 lakh crore by fiscal 2030. Private healthcare providers are expanding their market share of treatments from 64% in fiscal 2020 to an anticipated 69% by 2030, reflecting strong consumer preference for organized healthcare services.

Antique’s analysis underscores capacity expansion as a key growth catalyst, with 15 hospitals under coverage adding approximately 19,000 beds during fiscal 2023-26, raising the total to over 70,000 beds. The plan includes a further 54% increase in bed capacity by fiscal 2030, exceeding 1.08 lakh beds, fueled by predominantly brownfield expansion projects known for faster ramp-ups and higher returns.

Individual Hospital Chain Insights and Ratings

Apollo Hospitals Enterprise Ltd. – Buy

Apollo Hospitals operates 8,131 beds and features a diversified healthcare platform spanning hospitals, pharmacy distribution, digital health, and diagnostics. Antique has assigned a ‘Buy’ rating with a target price of Rs 9,790, suggesting approximately 14% upside.

Projected growth metrics for Apollo over fiscal 2026-28 include:

• Revenue CAGR: 16%
• EBITDA CAGR: 20%
• PAT CAGR: 24%
• Average revenue per patient CAGR: 6%
• Occupancy projected to exceed 68%

Expansion plans include adding around 1,000 beds through brownfield expansions and acquisitions.

Global Health Ltd. (Medanta) – Buy

Medanta operates six hospitals with 3,665 beds and plans to add approximately 490 beds via brownfield expansions in fiscal 2027. Antique’s target price is Rs 1,520 with an upside potential of about 15%.

Key growth estimates include:

• Revenue CAGR: 18%
• EBITDA CAGR: 25%
• PAT CAGR: 22%
• EBITDA margin expansion by 290 basis points to 24.6%
• EBITDA per bed growth at 16% CAGR to Rs 65 lakh

The Noida facility is expected to break even in the latter half of fiscal 2027, with mature hospitals improving profitability.

Healthcare Global Enterprises Ltd. (HCG) – Buy

HCG, India’s only listed pure-play oncology hospital network, operates over 2,600 beds across 25 centers in 19 cities. Antique highlights its 1,000-bed expansion pipeline by fiscal 2030, consisting of around 600 brownfield and 400 greenfield beds.

Antique assigns HCG a ‘Buy’ rating with a target price of Rs 840, implying an upside of about 37%, the highest among the covered hospitals.

Projected financials for fiscal 2026-28 are:

• Revenue CAGR: 16%
• EBITDA CAGR: 25%
• PAT CAGR: 116%

Earnings growth is expected to be driven by higher utilization, improved payor mix, operational efficiency, and brownfield expansions under KKR’s ownership.

Max Healthcare Institute Ltd. – Hold

Max Healthcare operates over 6,100 beds in 21 healthcare facilities, with plans to increase capacity by about 66% to 10,200 beds by fiscal 2030. Approximately 88% of this expansion will be through brownfield projects and asset-light operations.

Financial forecasts include:

• Revenue CAGR: 19%
• EBITDA CAGR: 21%
• PAT CAGR: 19%

Despite a strong operating outlook, Antique has rated Max Healthcare as ‘Hold’ due to its current valuation premium after a significant recent price run-up.

Artemis Medicare Services – Buy

Antique reiterates its ‘Buy’ rating for Artemis Medicare Services with a target price of Rs 340, signaling a potential upside of about 29%. Artemis plans to increase bed capacity to approximately 2,200 from 700, by adding 1,450 beds over the next three to four years across Gurugram, Raipur, and South Delhi.

Financial projections for Artemis include a CAGR of:

• Revenue: 27%
• EBITDA: 34%
• PAT: 36%

EBITDA margins are expected to expand by 190 basis points to 19.3% owing to operating leverage improvements as the network scales.

Positive Sector Outlook and Policy Support

Concerns about hospital overcapacity are considered overstated by Antique. Strong demand is supported by several factors:

• Increasing insurance penetration
• Government programs like Ayushman Bharat and PM-JAY
• Growing medical tourism
• Higher incidence of chronic diseases
• Market share gains by organized hospital chains

Supportive policy developments include revised building height norms, Competition Commission of India’s orders on integrated healthcare models, and updated CGHS tariffs. These trends create a favorable environment for organized hospital chains to expand and improve earnings.

Conclusion

India’s organized hospital sector is set for a robust growth trajectory driven by capacity addition, improved occupancy, favorable case mix, and healthy balance sheets. Antique’s coverage initiation and reaffirmation of these leading hospital stocks come with optimistic earnings growth expectations.

While Apollo Hospitals, Global Health (Medanta), Healthcare Global Enterprises (HCG), and Artemis Medicare Services are rated ‘Buy’ for their strong growth prospects, Max Healthcare commands a ‘Hold’ rating due to valuation considerations despite a solid growth outlook.

Disclaimer: The financial ratings, target prices, and growth metrics presented are for informational and educational purposes only and do not constitute investment advice. Investing in hospital stocks involves risks like execution on expansion plans, changes in domestic regulations, and market volatility. Readers should consult a SEBI-registered investment advisor before investing.